Who owns Merrimack Pharma Inc?
- Ticker: MACK
- CUSIP Number: 590328209
Tip: Access positions for across all investors
Analyze quarterly positions in Merrimack Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Merrimack Pharma stock
Who bought or sold Merrimack Pharma Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Western Standard | 2.2M | $29M | 15% | Dec 2023 |
|
| Newtyn Management | 1.9M | $25M | 0% | Dec 2023 |
|
| Vanguard Group | 609k | $8.2M | 1% | Dec 2023 |
|
| Madison Avenue Partners | 553k | $7.4M | 0% | Dec 2023 |
|
| ADAR1 Capital Management | 549k | $7.4M | 100% | Dec 2023 |
|
| Dimensional Fund Advisors | 436k | $5.8M | -3% | Dec 2023 |
|
| Sepio Capital | 307k | $4.1M | 0% | Dec 2023 |
|
| Indaba Capital Management | 224k | $3.0M | 63% | Dec 2023 |
|
| Caption Management | 126k | $1.7M | 12% | Dec 2023 |
|
| Bank of New York Mellon | 95k | $1.4M | -5% | Mar 2024 |
|
| Kennedy Capital Management | 46k | $620k | -51% | Dec 2023 |
|
| Goldman Sachs Group | 35k | $472k | 1% | Dec 2023 |
|
| Citadel Advisors | 34k | $460k | -60% | Dec 2023 |
|
| Charles Schwab Investment Management | 30k | $397k | 0% | Dec 2023 |
|
| Two Sigma Investments | 22k | $293k | 100% | Dec 2023 |
|
| Barclays | 14k | $193k | 679% | Dec 2023 |
|
| Rhumbline Advisers | 14k | $187k | 1% | Dec 2023 |
|
| UBS Group | 13k | $177k | 126% | Dec 2023 |
|
| Bank of America Corporation | 13k | $168k | 107% | Dec 2023 |
|
| Jpmorgan Chase & Co | 6.8k | $91k | 0% | Dec 2023 |
|
| MetLife Investment Advisors | 5.6k | $75k | 0% | Dec 2023 |
|
| American International | 5.2k | $70k | 0% | Dec 2023 |
|
| Royal Bank of Canada | 3.5k | $48k | 160% | Dec 2023 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 3.3k | $44k | 100% | Dec 2023 |
|
| Bnp Paribas Arbitrage, Snc | 3.0k | $41k | 97% | Dec 2023 |
|
| Lazard Asset Management | 2.8k | $37k | -9% | Dec 2023 |
|
| Wells Fargo & Company | 2.8k | $38k | 28% | Dec 2023 |
|
| Citigroup | 1.6k | $21k | 6450% | Dec 2023 |
|
| AJOVista | 1.5k | $21k | 100% | Dec 2023 |
|
| New York State Common Retirement Fund | 1.3k | $17k | -84% | Dec 2023 |
|
| Legal & General Group | 1.3k | $17k | 0% | Dec 2023 |
|
| Russell Investments | 1.1k | $14k | 23% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 979.00 | $13k | 8% | Dec 2023 |
|
| Summit Investment Advisors | 865.00 | $12k | 0% | Dec 2023 |
|
| Metropolitan Life Insurance Company | 581.00 | $7.8k | 0% | Dec 2023 |
|
| Amalgamated Bank | 353.00 | $5.0k | -76% | Mar 2024 |
|
| Sandy Spring Bank | 300.00 | $4.0k | 0% | Dec 2023 |
|
| Headlands Technologies | 300.00 | $4.0k | 100% | Dec 2023 |
|
| Rise Advisors | 272.00 | $4.0k | 0% | Mar 2024 |
|
| TSFG | 160.00 | $2.0k | 0% | Mar 2024 |
|
| Covestor | 106.00 | $1.0k | 22% | Dec 2023 |
|
| Federated Investors | 85.00 | $1.1k | -3% | Dec 2023 |
|
| Horrell Capital Management | 50.00 | $1.0k | 0% | Mar 2024 |
|
| Armstrong Advisory Group | 45.00 | $603.999000 | 0% | Mar 2024 |
|
| Capital Advisors | 28.00 | $0 | 100% | Mar 2024 |
|
| NISA Investment Advisors | 15.00 | $201.000000 | 0% | Dec 2023 |
|
| Pnc Financial Services | 8.00 | $107.000000 | 100% | Dec 2023 |
|
| CWM | 5.00 | $0 | 100% | Mar 2024 |
|
| GAMMA Investing | 2.00 | $30.000000 | 0% | Mar 2024 |
|
Who sold out of Merrimack Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Centiva Capital | Sep 2023 | 188k | $2.3M |
| Rosalind Advisors | Dec 2023 | 60k | $805k |
| Allspring Global Investments Holdings | Dec 2023 | 12k | $159k |
| Fifth Lane Capital | Sep 2023 | 11k | $134k |
| Mascoma Wealth Management | Sep 2023 | 5.0k | $62k |